Across TCGA pan-cancer cohorts, HLA-J Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated HLA-J data layer compared with 25 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher HLA-J Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated HLA-J expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

SKCM are the cancer types where HLA-J Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	1.000	0.229	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: HLA-J tumor-vs-normal RNA expression · all HLA-J data types